drugset / Trial / NCT02432456

Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients

NCT02432456

Phase 4 Completed 153 enrolled Medical College of Wisconsin
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will evaluate the effectiveness of ketamine infusions in the management of acute pain resulting from broken ribs suffered following a blunt trauma. Half of patients will receive the institutional standard of care and a placebo infusion (no active medication). The other half of patients will receive the institutional standard of care and a ketamine infusion. All subjects and staff will be blinded as to whether they are receiving placebo or ketamine.

Timeline

Start
2015-09
Primary completion
2018-08
Completion
2018-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 2 ug/kg
Subject Ketamine Small molecule 0.15 mg/kg
Background Acetaminophen Small molecule 650 mg Oral
Background Acetaminophen Small molecule 1000 mg Oral
Background Ibuprofen Small molecule 600 mg
Background Methocarbamol Small molecule 500 mg Oral
Background Pantoprazole Other / unclassified 40 mg Oral

Indications

No indication recorded.